PRE

SellHot Air

Prenetics Global Limited · Consumer Defensive · Hong Kong · $381M cap · $4.2M/day traded

$21.16 -3.1% · close 12 Oct · scored 14 Oct

StockRank down 1.3 since 13 Oct: Momentum down 3.

Hot Air: Rising on momentum alone: weak business, rich price.

28
StockRank
Get score and insider alerts
Quality
32
Value
23
Momentum
60

As of 14 Oct 2026, MoatMap's StockRank for Prenetics Global Limited (PRE) is 28/100, ranked against 24,000+ stocks in 35 markets (Quality 32, Value 23, Momentum 60, each scored against its sector).

Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →

P/E (TTM)
—
peers 10.1x
ROE
-47.0%
peers 6.3%
D/E
0.0x
peers 0.2x
Dividend %
—
trailing yield

ABOUT PRENETICS GLOBAL LIMITED

Read

Prenetics Global Limited is a global leader in genomics and diagnostics, offering a range of genetic testing and health screening solutions, including preventative health and infectious disease testing. The company's competitive advantage stems from its advanced laboratory capabilities, proprietary technology, and broad geographical reach, particularly in Asia. It plays a significant role in making personalized and preventative health accessible.

FINANCIAL SUMMARY (USD)

Year20212022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue—13.2M6.2M15.9M92.4M91.5%154.6M223.9M—142.4%
EPS-23.52-37.50-5.58-3.71-4.15—-3.10-3.37-2.62—
Shares—9.1M12.2M12.8M16.7M+83.2%17.9M———
Debt—6.6M2.4M5.8M1.8M-35.7%0.7M———
Equity—237.1M206.4M170.4M156.5M-12.9%————
Op CF—14.5M-13.8M-28.9M-21.8M—-40.5M———
Inv CF—-46.1M-83.0M38.5M-35.7M—————
Fin CF—143.3M-4.7M-3.3M37.5M—————
Loading 1Y...
PRICE (1Y) · USD-19.4%
20.221.723.224.726.331 Aug22 Sep12 Oct
SMA 50SMA 200

Price checkNo clear trendExperimental

No clear trend: not near its 52-week low, and not in a steady uptrend.

SwingsVery bumpy

Swung more than 91% of stocks we rank over the past year (85% a year).

How this is worked out

StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.

The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.

In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.

What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.

What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.

Calm is not safe: a calm stock can still slide steadily.

Rules fixed before any data was fetched. Describes the chart, not a recommendation.

Close
$21.16
RSI (14)
40.0
52-Week Range-22.3% from high
Low $11.36High $27.24

SCORE BREAKDOWN

Quality
32
ROIC
-20.8%2.8
ROE
-47.0%2.2
GP/Assets
43.3%75.4
Op. Margin
-45.1%2.2
FCF/Assets
-37.1%1.2
Piotroski
528.2
Int. Cover
-50.0x0.8
D/E Ratio
0.01x92.4
Current Ratio
4.04x88.7
Value
23
P/E (TTM)
—N/A
EV/EBITDA
-4.6x25.0
P/FCF
—N/A
P/B
4.1x18.1
P/S
2.8x18.3
Div Yield
—N/A
Momentum
60
52W High %
78%47.9
RS 6M
2%71.8
SMA 50/200
1.14x91.2
EPS Rev 4W
+2.2%93.2
EPS Rev 12W
—N/A
EPS Improve
+16%35.2
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$381M
P/E (Forward)
-8.3x
Gross Margin
57.8%

SECTOR PEERS

Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of PRE are excluded.

TickerCompanyMkt CapStockRankSignal
PREPrenetics Global Limited(you)$381M28Sell
1717.HKAusnutria Dairy Corporation Ltd$241M22Sell
0829.HKShenguan Holdings (Group) Limited$99M27Sell
9876.HKOcean One Holding Ltd.$108M42Hold
1475.HKNissin Foods Company Limited$889M54Hold
0809.HKGlobal Bio-chem Technology Group Company Limited$80M14Strong Sell
0345.HKVitasoy International Holdings Limited$848M76Buy
3838.HKChina Starch Holdings Limited$130M75Buy
0142.HKFirst Pacific Company Limited$2.6B84Strong Buy
0151.HKWant Want China Holdings Limited$4.1B78Buy

Peer medians: ROE 6.3% · P/E 10.1x · Gross margin 36.8%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Prenetics Global Limited (PRE): Stock Score Summary

Prenetics Global Limited (PRE) has a MoatMap StockRank of 28/100 based on Quality (32/100), Value (23/100), and Momentum (60/100) factor scores. The current signal is SELL.

Prenetics Global Limited is a global leader in genomics and diagnostics, offering a range of genetic testing and health screening solutions, including preventative health and infectious disease testing. The company's competitive advantage stems from its advanced laboratory capabilities, proprietary technology, and broad geographical reach, particularly in Asia. It plays a significant role in making personalized and preventative health accessible.

Key Financial Metrics

Price$21.16
Market Cap$381M
P/E (Forward)-8.35
Price/Book4.05
Return on Equity-47.0%
Return on Invested Capital-20.8%
Debt/Equity0.01x
Gross Margin57.8%
Operating Margin-45.1%
Revenue Growth210.7%
Free Cash Flow$-76M

Prenetics Global Limited operates in the Packaged Foods industry, part of the Consumer Defensive sector (Hong Kong).

Frequently Asked Questions

What is Prenetics Global Limited’s (PRE) StockRank?
MoatMap’s StockRank for Prenetics Global Limited (PRE) is 28/100, with a Sell signal. It is a composite of Quality (32), Value (23), and Momentum (60), each scored against its sector. The composite is then ranked across MoatMap’s universe of 24,000+ stocks.
Does Prenetics Global Limited have an economic moat?
Prenetics Global Limited (PRE) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Prenetics Global Limited a buy, hold, or sell?
MoatMap’s current signal for Prenetics Global Limited (PRE) is Sell, based on a StockRank of 28/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Prenetics Global Limited in?
Prenetics Global Limited (PRE) operates in the Consumer Defensive sector, specifically the Packaged Foods industry (Hong Kong).